SurModics, Inc.
SRDX
$37.19
$1.103.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.02% | -14.96% | -9.23% | -4.91% | -7.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.02% | -14.96% | -9.23% | -4.91% | -7.49% |
| Cost of Revenue | 24.10% | 33.36% | 30.72% | 170.22% | 148.15% |
| Gross Profit | -5.73% | -24.27% | -17.80% | -22.69% | -19.46% |
| SG&A Expenses | -6.55% | -2.51% | -1.20% | -3.18% | -1.30% |
| Depreciation & Amortization | 0.49% | -0.91% | 0.00% | -1.02% | -3.61% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.83% | -1.49% | -1.07% | -1.46% | -2.91% |
| Operating Income | 131.73% | -105.81% | -91.24% | -82.96% | -417.53% |
| Income Before Tax | -60.43% | -184.23% | -199.54% | -401.81% | -504.09% |
| Income Tax Expenses | 137.83% | 39.15% | 10.14% | 0.32% | -136.19% |
| Earnings from Continuing Operations | -1,159.97% | -247.12% | -360.95% | -651.43% | 93.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,159.97% | -247.12% | -360.95% | -651.43% | 93.91% |
| EBIT | 131.73% | -105.81% | -91.24% | -82.96% | -417.53% |
| EBITDA | 140.15% | -72.74% | -55.08% | -31.69% | -58.90% |
| EPS Basic | -1,197.90% | -245.49% | -359.07% | -618.80% | 94.21% |
| Normalized Basic EPS | 86.15% | -119.01% | -108.03% | -131.29% | -438.25% |
| EPS Diluted | -1,144.51% | -247.73% | -366.89% | -607.28% | 93.93% |
| Normalized Diluted EPS | 86.11% | -119.03% | -108.04% | -131.44% | -422.50% |
| Average Basic Shares Outstanding | 0.87% | 0.89% | 0.88% | 0.87% | 0.86% |
| Average Diluted Shares Outstanding | 0.66% | 0.64% | 0.74% | 0.72% | 1.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |